Mass. to end contract with Biobot for wastewater surveillance

Key Points:

• Biobot Analytics, founded by two MIT students in 2017, pioneered wastewater surveillance to detect viruses like COVID-19 early, becoming a key public health tool during the pandemic by analyzing genetic material in sewage samples.
• Since the pandemic, wastewater monitoring has shifted from emergency response to routine public health practice, with states like Massachusetts ending contracts with Biobot to build in-house testing programs focused on fewer pathogens and lower costs.
• Despite losing major contracts such as with the CDC (now awarded to a Google-affiliated company), Biobot continues to innovate by offering broad surveillance for numerous diseases and drug use, serving dozens of communities and federal agencies across 40 states.
• Massachusetts and other states are developing independent wastewater testing capabilities to reduce reliance on private vendors, though Biobot’s CEO warns this could slow technological advancement and reduce the scope of detectable pathogens.
• Biobot has launched a public dashboard tracking over 1,500 viruses and remains optimistic about the future of wastewater epidemiology, comparing its initial skepticism to the early reception of transformative technologies like the iPhone.